Prime Minister Narendra Modi said on Monday that the world’s biggest inoculation drive against coronavirus is set to begin in the country, a day after the drugs regulator approved two vaccines for restricted emergency use.
Lauding the scientists and technicians for the ‘Made in India’ vaccines, he said the country is proud of them.
“World’s biggest COVID-19 vaccination programme set to begin in India. For this, the country is proud of the contributions of its scientists and technicians,” Modi said.
Addressing scientists at the National Metrology Conclave, Mr. Modi said it must be ensured that ‘Made in India’ products not only have global demand but also global acceptance.
“Quality is as much important as quantity, our standards should rise with our scale in our quest for Aatmanirbhar Bharat,” he said.
India’s drugs regulator on Sunday approved Oxford COVID-19 vaccine Covishield, manufactured by the Serum Institute, and indigenously developed Covaxin of Bharat Biotech for restricted emergency use in the country, paving the way for a massive inoculation drive.
You have reached your limit for free articles this month.
Subscription Benefits Include
Today's Paper
Find mobile-friendly version of articles from the day's newspaper in one easy-to-read list.
Unlimited Access
Enjoy reading as many articles as you wish without any limitations.
Personalised recommendations
A select list of articles that match your interests and tastes.
Faster pages
Move smoothly between articles as our pages load instantly.
Dashboard
A one-stop-shop for seeing the latest updates, and managing your preferences.
Briefing
We brief you on the latest and most important developments, three times a day.
Support Quality Journalism.
*Our Digital Subscription plans do not currently include the e-paper, crossword and print.
A letter from the Editor
Dear subscriber,
Thank you!
Your support for our journalism is invaluable. It’s a support for truth and fairness in journalism. It has helped us keep apace with events and happenings.
The Hindu has always stood for journalism that is in the public interest. At this difficult time, it becomes even more important that we have access to information that has a bearing on our health and well-being, our lives, and livelihoods. As a subscriber, you are not only a beneficiary of our work but also its enabler.
We also reiterate here the promise that our team of reporters, copy editors, fact-checkers, designers, and photographers will deliver quality journalism that stays away from vested interest and political propaganda.
Suresh Nambath
